Search Results - "Trappe, U"

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study by Tiede, Andreas, Klamroth, Robert, Scharf, Rüdiger E., Trappe, Ralf U., Holstein, Katharina, Huth-Kühne, Angela, Gottstein, Saskia, Geisen, Ulrich, Schenk, Joachim, Scholz, Ute, Schilling, Kristina, Neumeister, Peter, Miesbach, Wolfgang, Manner, Daniela, Greil, Richard, von Auer, Charis, Krause, Manuela, Leimkühler, Klaus, Kalus, Ulrich, Blumtritt, Jan-Malte, Werwitzke, Sonja, Budde, Eva, Koch, Armin, Knöbl, Paul

“…Acquired hemophilia A (AHA) is caused by autoantibodies against factor VIII (FVIII). Immunosuppressive treatment (IST) results in remission of disease in 60%…”
Get full text

EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity by Gandhi, M.K., Hoang, T., Law, S.C., Brosda, S., O'Rourke, K., Tobin, J.W.D., Vari, F., Murigneux, V., Fink, L., Gunawardana, J., Gould, C., Oey, H., Bednarska, K., Delecluse, S., Trappe, R.U., Merida de Long, L., Sabdia, M.B., Bhagat, G., Hapgood, G., Blyth, E., Clancy, L., Wight, J., Hawkes, E., Rimsza, L.M., Maguire, A., Bojarczuk, K., Chapuy, B., Keane, C.

“…Primary central nervous system lymphoma (PCNSL) is confined to the brain, eyes, and cerebrospinal fluid without evidence of systemic spread. Rarely, PCNSL…”
Get full text

Effect of Anti‐CD 20 Antibody Rituximab in Patients with Post‐Transplant Lymphoproliferative Disorder (PTLD) by Oertel, Stephan H.K., Verschuuren, Erik, Reinke, Petra, Zeidler, Kristin, Papp‐Váry, Matthias, Babel, Nina, Trappe, Ralf U., Jonas, Sven, Hummel, Manfred, Anagnostopoulos, Ioannis, Dörken, Bernd, Riess, Hanno B.

“…Post‐transplant lymphoproliferative disorders (PTLD) are a life‐threatening complication following solid organ transplantation. Treatment with rituximab, a…”
Get full text

Host microRNAs are decreased in pediatric solid-organ transplant recipients during EBV+ Post-transplant Lymphoproliferative Disorder by Sen, Ayantika, Enriquez, Jeanna, Rao, Mahil, Glass, Marla, Balachandran, Yarl, Syed, Sharjeel, Twist, Clare J., Weinberg, Kenneth, Boyd, Scott D., Bernstein, Daniel, Trickey, Amber W., Gratzinger, Dita, Tan, Brent, Lapasaran, Mary Gay, Robien, Mark A., Brown, Merideth, Armstrong, Brian, Desai, Dev, Mazariegos, George, Chin, Clifford, Fishbein, Thomas M., Venick, Robert S., Tekin, Akin, Zimmermann, Heiner, Trappe, Ralf U., Anagnostopoulos, Ioannis, Esquivel, Carlos O., Martinez, Olivia M., Krams, Sheri M.

“…Post-transplant lymphoproliferative disorder (PTLD) is a serious complication of solid organ transplantation. Predisposing factors include primary Epstein-Barr…”
Get full text

A Comprehensive Analysis of the Cellular and EBV‐Specific MicroRNAome in Primary CNS PTLD Identifies Different Patterns Among EBV‐Associated Tumors by Fink, S. E. K., Gandhi, M. K., Nourse, J. P., Keane, C., Jones, K., Crooks, P., Jöhrens, K., Korfel, A., Schmidt, H., Neumann, S., Tiede, A., Jäger, U., Dührsen, U., Neuhaus, R., Dreyling, M., Borchert, K., Südhoff, T., Riess, H., Anagnostopoulos, I., Trappe, R. U.

“…Primary central nervous system (pCNS) posttransplant lymphoproliferative disorder (PTLD) is a complication of solid organ transplantation characterized by poor…”
Get full text

Plasmablastic Posttransplant Lymphoma: Cytogenetic Aberrations and Lack of Epstein-Barr Virus Association Linked With Poor Outcome in the Prospective German Posttransplant Lymphoproliferative Disorder Registry by ZIMMERMANN, Heiner, OSCHLIES, Ilske, ANAGNOSTOPOULOS, Ioannis, RIESS, Hanno, KLAPPER, Wolfram, TRAPPE, Ralf U, FINK, Susanne, POTT, Christiane, NEUMAYER, Hans H, LEHMKUHL, Hans, HAUSER, Ingeborg A, DREYLING, Martin, KNEBA, Michael, GÄRTNER, Barbara

“…Plasmablastic posttransplant lymphoma is a rare subtype of monomorphic B-cell posttransplant lymphoproliferative disorder (PTLD). There is little published…”
Get full text

Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial by Trappe, Ralf U, Dierickx, Daan, Zimmermann, Heiner, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M, Dreyling, Martin H, Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Salles, Gilles, Kliem, Volker, Hauser, Ingeborg A, Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain

“…Purpose The Sequential Treatment of CD20-Positive Posttransplant Lymphoproliferative Disorder (PTLD-1) trial ( ClinicalTrials.gov identifier, NCT01458548)…”
Get full text

Salvage Therapy for Relapsed Posttransplant Lymphoproliferative Disorders (PTLD) With a Second Progression of PTLD After Upfront Chemotherapy : The Role of Single-Agent Rituximab by TRAPPE, Ralf U, CHOQUET, Sylvain, LEBLOND, Véronique, HETZER, Roland, DÖRKEN, Bernd, RIESS, Hanno, OERTEL, Stephan, REINKE, Petra, DREYLING, Martin, MERGENTHALER, Hans-Gunther, JÄGER, Ulrich, KEBELMANN-BETZING, Christian, JONAS, Sven, LEHMKUHL, Hans, ANAGNOSTOPOULOS, Ioannis

“…Currently no standard treatment exists for patients with posttransplant lymphoproliferative disorders relapsed or refractory to chemotherapy after failure of…”
Get full text

Fc γ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder by Riess, Hanno, Trappe, Ralf U., Oertel, Stephan, Gärtner, Barbara, Karbasiyan, Mohsen, Neuhaus, Ruth, Reinke, Petra, Gandhi, Maher K., Nourse, Jamie P., Weiland, Theresa, Zimmermann, Heiner, Anagnostopoulos, Ioannis

“…We retrospectively analyzed the p.V158F polymorphism of Fcγ-receptor IIIA (FCGR3A, CD16) in patients with PTLD treated with rituximab monotherapy. Previous…”
Get full text

Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial by Zimmermann, Heiner, Koenecke, Christian, Dreyling, Martin H., Pott, Christiane, Dührsen, Ulrich, Hahn, Dennis, Meidenbauer, Norbert, Hauser, Ingeborg A., Rummel, Mathias J., Wolf, Dominik, Heuser, Michael, Schmidt, Christian, Schlattmann, Peter, Ritgen, Matthias, Siebert, Reiner, Oschlies, Ilske, Anagnostopoulos, Ioannis, Trappe, Ralf U.

“…The prospective multicentre Phase II PTLD-2 trial (NCT02042391) tested modified risk-stratification in adult SOT recipients with CD20-positive PTLD based on…”
Get full text

End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry by Zimmermann, Heiner, Denecke, Timm, Dreyling, Martin H, Franzius, Christiane, Reinke, Petra, Subklewe, Marion, Amthauer, Holger, Kneba, Michael, Riess, Hanno, Trappe, Ralf U

“…BACKGROUNDFluorine-18 fluorodeoxyglucose (18F-FDG)-positron emission tomography (PET) is a recommended standard in the staging and response assessment of…”
Get full text

P1107: CLINICAL OUTCOMES OF SOLID ORGAN TRANSPLANT PATIENTS WITH EBV+ PTLD WHO FAIL RITUXIMAB PLUS CHEMOTHERAPY: A MULTINATIONAL, RETROSPECTIVE CHART REVIEW STUDY by Dharnidharka, V., Thirumalai, D., Jaeger, U., Zhao, W., Dierickx, D., Xun, P., Minga, P., Sawas, A., Sadetsky, N., Chauvet, P., Sundaram, E., Barlev, A., Zimmerman, H., Trappe, R. U.

Get full text

EBV and posttransplantation lymphoproliferative disease: what to do? by Zimmermann, Heiner, Trappe, Ralf U

“…This review summarizes the available evidence and outlines our approach to the prophylaxis and management of posttransplantation lymphoproliferative disorder…”
Get full text

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.) by Kreher, Stephan, Ochsenreither, Sebastian, Trappe, Ralf U., Pabinger, Ingrid, Bergmann, Frauke, Petrides, Petro E., Koschmieder, Steffen, Matzdorff, Axel, Tiede, Andreas, Griesshammer, Martin, Riess, Hanno

“…Patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) like polycythemia vera and essential thrombocythemia are at increased risk of…”
Get full text

Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study by Chaganti, Sridhar, Barlev, Arie, Caillard, Sophie, Choquet, Sylvain, Cwynarski, Kate, Friedetzky, Anke, González-Barca, Eva, Sadetsky, Natalia, Schneeberger, Stefan, Thirumalai, Dhanalakshmi, Zinzani, Pier L., Trappe, Ralf U.

“…Introduction Following hematopoietic stem cell transplantation or solid organ transplantation, patients are at risk of developing Epstein–Barr virus-positive…”
Get full text

The IPTA Nashville Consensus Conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: III – Consensus guidelines for Epstein‐Barr virus load and other biomarker monitoring by Preiksaitis, Jutta, Allen, Upton, Bollard, Catherine M., Dharnidharka, Vikas R., Dulek, Daniel E., Green, Michael, Martinez, Olivia M., Metes, Diana M., Michaels, Marian G., Smets, Françoise, Chinnock, Richard E., Comoli, Patrizia, Danziger‐Isakov, Lara, Dipchand, Anne I., Esquivel, Carlos O., Ferry, Judith A., Gross, Thomas G., Hayashi, Robert J., Höcker, Britta, L’Huillier, Arnaud G., Marks, Stephen D., Mazariegos, George Vincent, Squires, James, Swerdlow, Steven H., Trappe, Ralf U., Visner, Gary, Webber, Steven A., Wilkinson, James D., Maecker‐Kolhoff, Brtitta

“…The International Pediatric Transplant Association convened an expert consensus conference to assess current evidence and develop recommendations for various…”
Get full text

Elucidation of the miRNome in EBV-positive and EBV-negative PTLD by Balachandran, Yarl, Zimmermann, Heiner, Esquivel, Carlos O, Krams, Sheri, Trappe, Ralf U, Martinez, Olivia M

“…Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation characterized by abnormal proliferation of…”
Get full text

The IPTA Nashville consensus conference on Post‐Transplant lymphoproliferative disorders after solid organ transplantation in children: II—consensus guidelines for prevention by Green, Michael, Squires, James E., Chinnock, Richard E., Comoli, Patrizia, Danziger‐Isakov, Lara, Dulek, Daniel E., Esquivel, Carlos O., Höcker, Britta, L'Huillier, Arnaud G., Mazariegos, George Vincent, Visner, Gary A., Bollard, Catherine M., Dipchand, Anne I., Ferry, Judith A., Gross, Thomas G., Hayashi, Robert, Maecker‐Kolhoff, Britta, Marks, Stephen, Martinez, Olivia M., Metes, Diana M., Michaels, Marian G., Preiksaitis, Jutta, Smets, Françoise, Swerdlow, Stephen H., Trappe, Ralf U., Wilkinson, James D., Allen, Upton, Webber, Steven A., Dharnidharka, Vikas R.

“…The International Pediatric Transplant Association (IPTA) convened an expert consensus conference to assess current evidence and develop recommendations for…”
Get full text

Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry by Zimmermann, Heiner, Nitsche, Mirko, Pott, Christiane, Reinke, Petra, Babel, Nina, Hermann, Robert M., Hauser, Ingeborg A., Hahn, Dennis, Ritgen, Matthias, Pietschmann, Claudia, Klapper, Wolfram, Anagnostopoulos, Ioannis, Trappe, Ralf U.

“…Post-transplant lymphoproliferative disorders (PTLD) exclusively affecting the central nervous system—primary CNS-PTLD (pCNS-PTLD)—are rare. There is no…”
Get full text

Immunosuppression Is Associated With Clinical Features and Relapse Risk of B Cell Posttransplant Lymphoproliferative Disorder: A Retrospective Analysis Based on the Prospective, International, Multicenter PTLD-1 Trials by Zimmermann, Heiner, Babel, Nina, Dierickx, Daan, Morschhauser, Franck, Mollee, Peter, Zaucha, Jan M, Dreyling, Martin H, Dührsen, Ulrich, Reinke, Petra, Verhoef, Gregor, Subklewe, Marion, Hüttmann, Andreas, Tousseyn, Thomas, Bachy, Emmanuel, Hauser, Ingeborg A, Tarella, Corrado, Van Den Neste, Eric, Gheysens, Olivier, Anagnostopoulos, Ioannis, Leblond, Veronique, Riess, Hanno, Choquet, Sylvain, Trappe, Ralf U

“…BACKGROUNDCurrent guideline recommendations for immunosuppression reduction after diagnosis of posttransplant lymphoproliferative disorder (PTLD) include…”
Get full text